The future of P2Y12 receptor antagonists.

  title={The future of P2Y12 receptor antagonists.},
  author={Mark R. P. Thomas and Robert F. Storey},
  volume={26 5},
Platelet P2Y12 inhibitors have become a central component of the treatment strategy for patients with atherothrombosis due to the importance of platelet P2Y12 receptors in arterial thrombosis. P2Y12 inhibitors effectively reduce the risk of adverse cardiovascular events in patients with acute coronary syndromes (ACS) and patients undergoing percutaneous coronary intervention (PCI). However, despite this, patients with ACS continue to suffer from recurrent atherothrombosis and an increased risk… CONTINUE READING

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…